(DMAC) Diamedica Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Diamedica Therapeutics | (DMAC) share price targets
Complete technical analysis of Diamedica Therapeutics (DMAC) by charts plus indicators, forecast predictions and share price targets for Diamedica Therapeutics (DMAC)
Diamedica Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-10-28 View latest technical analysis
10 day averaged volume of Diamedica Therapeutics is 282910
| Date | Daily Closing Price | Open | High | Low | Volume |
| 28 Tue Oct 2025 | 6.79 | 6.86 | 6.94 | 6.71 | 0.463 times |
| 27 Mon Oct 2025 | 6.88 | 6.91 | 7.10 | 6.77 | 0.952 times |
| 24 Fri Oct 2025 | 6.88 | 6.91 | 6.93 | 6.70 | 1.094 times |
| 23 Thu Oct 2025 | 6.76 | 6.75 | 6.88 | 6.67 | 0.952 times |
| 22 Wed Oct 2025 | 6.71 | 6.60 | 6.76 | 6.49 | 1.53 times |
| 21 Tue Oct 2025 | 6.62 | 6.77 | 6.77 | 6.60 | 0.947 times |
| 20 Mon Oct 2025 | 6.77 | 6.65 | 6.81 | 6.63 | 0.677 times |
| 17 Fri Oct 2025 | 6.58 | 6.65 | 6.73 | 6.45 | 0.864 times |
| 16 Thu Oct 2025 | 6.68 | 7.05 | 7.24 | 6.65 | 1.649 times |
| 15 Wed Oct 2025 | 7.05 | 6.90 | 7.05 | 6.81 | 0.75 times |
My analysis of stock is bearish for shortterm, and stock might move down till 6.7 or till 6.5. Use a stoploss of 6.84 and if the stock hits stoploss, then it can shoot up till 6.98
Share price targets for Diamedica Therapeutics (DMAC)
| Target Type | Value |
| Downside Target | 3.48 |
| Downside Target | 4.01 |
| Downside Target | 4.46 |
| Downside Target | 5.14 |
| Downside Target | 5.60 |
| Downside Target | 6.40 |
| Upside Target | 6.93 |
| Upside Target | 7.10 |
| Upside Target | 7.13 |
| Upside Target | 7.14 |
| Upside Target | 7.24 |
| Upside Target | 7.49 |
Intraday share price targets for Diamedica Therapeutics (DMAC)
| Target Type | Value |
| Downside Intraday Target | 6.63 |
| Downside Intraday Target | 6.48 |
| Upside Intraday Target | 7.02 |
| Upside Intraday Target | 7.26 |
| Upside Intraday Target | 6.87 |
Weekly technical analysis of Diamedica Therapeutics (DMAC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 28 Tue Oct 2025 | 6.79 | 6.91 | 7.10 | 6.71 | 0.272 times |
| 24 Fri Oct 2025 | 6.88 | 6.65 | 6.93 | 6.49 | 0.981 times |
| 17 Fri Oct 2025 | 6.58 | 6.65 | 7.24 | 6.45 | 1.248 times |
| 10 Fri Oct 2025 | 6.64 | 7.10 | 7.14 | 6.56 | 1.387 times |
| 03 Fri Oct 2025 | 7.07 | 6.95 | 7.13 | 6.66 | 0.591 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Diamedica Therapeutics (DMAC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 28 Tue Oct 2025 | 6.79 | 6.81 | 7.24 | 6.45 | 0.472 times |
| 30 Tue Sep 2025 | 6.87 | 5.71 | 7.49 | 5.14 | 1.682 times |
| 29 Fri Aug 2025 | 5.71 | 4.16 | 6.40 | 4.01 | 0.744 times |
| 31 Thu Jul 2025 | 4.22 | 3.90 | 5.60 | 3.48 | 1.502 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Diamedica Therapeutics (DMAC)
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Diamedica Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Diamedica Therapeutics in short term but the sell signal is initial and weak.
Diamedica Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Diamedica Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Diamedica Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.76 and Diamedica Therapeutics (DMAC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Diamedica Therapeutics (DMAC) stock. Volume based technical analysis of Diamedica Therapeutics (DMAC) stock is negative.
Diamedica Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Diamedica Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Diamedica Therapeutics in short term but the sell signal is initial and weak.
Diamedica Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Diamedica Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Diamedica Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.76 and Diamedica Therapeutics (DMAC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Diamedica Therapeutics (DMAC) stock. Volume based technical analysis of Diamedica Therapeutics (DMAC) stock is negative.
Diamedica Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.